NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
RHEACELL INNOVATIVE STEM CELL THERAPIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RHEACELL INNOVATIVE STEM CELL THERAPIES
ST13
US500000079307004Class
5, 42, 44
Filing
79307004
Registration
6696110
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/15/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
12/11/2020
Registration date
04/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2022
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RHEACELL GmbH & Co. KG
Representatives
Sean K. Owens Wood Herron & Evans LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugsdrug delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical and veterinary preparations for the treatment of skin diseasespharmaceutical and veterinary preparations for the treatment of vertigopharmaceutical and veterinary preparations for the treatment of nauseapharmaceutical and veterinary preparations for the treatment of vomitingpharmaceutical and veterinary preparations for the treatment of migrainepharmaceutical and veterinary preparations for the treatment of disease and disorders of the respiratory systemthe gastrointestinal systemthe endocrine systemthe cardiovascular systemthe nervous systemthe musculoskeletal systemthe urinary systemthe integumentary systemthe reproductive systempharmaceutical and veterinary preparations for the treatment of blood diseases and disorderspharmaceutical and veterinary preparationsantibioticsimmune suppressantsanti-inflammatory preparationspharmaceutical and veterinary preparations for wound healingpharmaceutical and veterinary preparations for anti-agingstem cells for medical and medical aesthetic purposesfibroblast cells for medical and medical aesthetic purposessurgical tissue implants comprised of living tissues obtained from fibroblasts; diagnostic agents for medical purposes; diagnostic preparations for medical and biomedical purposes; pharmaceutical cell preparations for medical use for the treatment of skin diseasesvertigonauseavomitingmigrainedisease and disorders of the respiratory systemdisease and disorders of the gastrointestinal systemdisease and disorders of the endocrine systemdisease and disorders of the cardiovascular systemdisease and disorders of the nervous systemdisease and disorders of musculoskeletal systemdisease and disorders of urinary systemdisease and disorders of integumentary systemdisease and disorders of the reproductive systemblood diseases and disorders; sterilizing substances for medical use; sterilizing substances for biomedical purposes; live implants comprising of live tissues for pharmaceutical purposes; biochemical and chemical productsbiochemical preparations for the treatment of skin diseases and chemical reagents for medical use; biochemical and chemical productsbiochemical preparations for the treatment of skin diseases and chemical reagents for pharmaceutical purposes; biochemical and chemical products for pharmaceutical or medical purposesbiochemical preparations for the treatment of skin diseasesvertigonauseavomitingmigrainedisease and disorders of the respiratory systemdisease and disorders of the gastrointestinal systemdisease and disorders of the endocrine systemdisease and disorders of the cardiovascular systemdisease and disorders of the nervous systemdisease and disorders of musculoskeletal systemdisease and disorders of urinary systemdisease and disorders of integumentary systemdisease and disorders of the reproductive systemblood diseases and disorders for diagnostic purposes; proteins being protein supplements for medical purposes; biological preparations for medical and veterinary purposespharmaceutical and veterinary preparationsall for external use for the treatment of skin diseaseswoundsulcersburns and surgical wounds; biologicalpharmaceutical and veterinary preparations for skin care for medical purposes; medical dressings; pharmaceutical preparations for wound treating and healing; biologicalpharmaceutical and veterinary preparations for the treatment of chronic woundsulcersburns and surgical wounds; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes for medical use; somatic stem cell therapeutics for medical purposes; pharmaceutical implantsimplantable surgery human allograft bonesbiological bone tissue graftscells for medical usebiological bone marrow tissue; surgical implants comprised of living stem cells; surgical implants comprised of living fibroblasts tissue cells; biological human skin and bone tissue intended for subsequent implantation; cell growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissuevascular grafts; biotechnologically engineered tissue productstissue cells in sheet form and plasters for wound healing and treating burns for medical purposesbiological eye lens tissue graftsbiological bone tissue grafts
Class 42
Pharmaceutical drug development; scientific and technological servicesnamely medical and pharmaceutical research services and technical research in the field of pharmaceutical studiesregenerative medicine and tissue engineering; research and development services in the fields of cell diagnostics and research and development services relating to new products for others in the field of therapy and surgical and medical instruments; industrial analysis and research servicesnamely analysis of industrial fluids and medical researchchemical analysis; scientific research for medical purposes in the field of stem cell therapies; stem cell research; scientific and medical research and development in the field of stem cells; scientific researchtesting and analysis services of the services of others to determine conformity with certification standards and in the field of regenerative medicine and tissue engineering; scientific research for medical purposes; medical research; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; product research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology
Class 44
Medical services; medical diagnostic services for carrying out tests and analyses; medical assistance; medical clinic services; hospital services; plastic and cosmetic surgery; medical therapiesstem cell therapy for treating medical conditions; medical services being human cells and tissue banksstem cell banks and bone marrow banksmedical services in the field of regenerative medicine and medical analysis services relating to the treatment of patients in the field of tissue engineering; medical services being banks of human tissue and stem cellsmedical services in the field of regenerative medicine and medical analysis services relating to the treatment of patients in the field of tissue engineering; medical services in the nature of stem cell banks for medical transplantation; medical services in the nature of cultured stem cell banks for medical transplantation
Publications
History of USPTO decisions and trademark events.
29 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/20/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/26/2022
FIMP
FINAL DISPOSITION PROCESSED
08/26/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/25/2022
PUBO
PUBLISHED FOR OPPOSITION
01/25/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/22/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/05/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2021
RFNT
REFUSAL PROCESSED BY IB
06/28/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/09/2021
RFRR
REFUSAL PROCESSED BY MPU
06/09/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/08/2021
CNRT
NON-FINAL ACTION WRITTEN
06/07/2021
DOCK
ASSIGNED TO EXAMINER
06/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/22/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/18/2021
Continuous trademark protection
Get notified about every new filing that threatens RHEACELL INNOVATIVE STEM CELL THERAPIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.